# Acute Liver Injury in Patients on Dapagliflozin

> **NCT02695095** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 424091 (actual)

## Conditions studied

- Acute Liver Injury

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02695095
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2020-09-01
- **Final completion:** 2020-11-30
- **Target enrollment:** 424091 (ACTUAL)
- **Last updated:** 2021-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02695095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02695095, "Acute Liver Injury in Patients on Dapagliflozin". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02695095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*